Anan Chuntharapai

2.9k total citations · 1 hit paper
30 papers, 2.4k citations indexed

About

Anan Chuntharapai is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Anan Chuntharapai has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 15 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in Anan Chuntharapai's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Cytokine Signaling Pathways and Interactions (8 papers) and T-cell and B-cell Immunology (5 papers). Anan Chuntharapai is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Cytokine Signaling Pathways and Interactions (8 papers) and T-cell and B-cell Immunology (5 papers). Anan Chuntharapai collaborates with scholars based in United States, France and Switzerland. Anan Chuntharapai's co-authors include David A. Lawrence, Avi Ashkenazi, Frank Kischkel, Peter Schow, C A Hébert, Avi Ashkenazi, Scot A. Marsters, Verna C. Gibbs, Kurt A. Schroeder and Katharine Grimmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Anan Chuntharapai

30 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5

2000 816 citations Frank Kischkel, David A. Lawrence et al. Immunity profile →

Peers

Countries citing papers authored by Anan Chuntharapai

Since Specialization

Citations

This map shows the geographic impact of Anan Chuntharapai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anan Chuntharapai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anan Chuntharapai more than expected).

Fields of papers citing papers by Anan Chuntharapai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anan Chuntharapai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anan Chuntharapai. The network helps show where Anan Chuntharapai may publish in the future.

Co-authorship network of co-authors of Anan Chuntharapai

This figure shows the co-authorship network connecting the top 25 collaborators of Anan Chuntharapai. A scholar is included among the top collaborators of Anan Chuntharapai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anan Chuntharapai. Anan Chuntharapai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum 2018 ·Journal of Immunological Methods ·John R. Lowe, Eric Wakshull, (unknown), Anan Chuntharapai, (unknown), Jeriza Rusit, Maurício Maia	11
2	A novel immunoassay to measure total serum lymphotoxin‐α levels in the presence of an anti-LTα therapeutic antibody 2015 ·Journal of Immunological Methods ·Judy Young, Allen Nguyen, Zhihua Qiu, Yong Ying, Xiaoying Gao, Chae Reed, Anan Chuntharapai, Rong Deng, Jeff Lutman, Jane L. Grogan, Wai Lee Wong, Laura DeForge	1
3	Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG 2013 ·mAbs ·Xiangdan Wang, Valerie Quarmby, Carl Ng, Anan Chuntharapai, (unknown), Charles Eigenbrot, Robert F. Kelley, Steven Shia, Krista McCutcheon, John R. Lowe, (unknown), (unknown), Gary A. Cain, Felix Chu, Isidro Hötzel, Mauricio Maia, Eric Wakshull, Jihong Yang	10
4	Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF 2010 ·Journal of Immunological Methods ·Laura DeForge, Kelly M. Loyet, Donnie Delarosa, (unknown), (unknown), Anan Chuntharapai, James Lee, Phil Hass, Nathan Wei, Michael J. Townsend, Jianyong Wang, Wai Lee Wong	26
5	Species-dependent serum interference in a sandwich ELISA for Apo2L/TRAIL 2007 ·Journal of Immunological Methods ·Laura DeForge, Danny Shih, Derek Kennedy, Klára Tótpál, Anan Chuntharapai, Gregory L. Bennett, (unknown), Patricia Siguenza, Wai Lee Wong	8
6	Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20 2004 ·Journal of Immunological Methods ·Kyu Hong, Leonard G. Presta, Yanmei Lu, (unknown), Camellia Adams, Anan Chuntharapai, Jihong Yang, Wai Lee Wong, Y. Gloria Meng	22
7	Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4 2001 ·The Journal of Immunology ·Anan Chuntharapai, (unknown), Katharine Grimmer, Kurt A. Schroeder, Scot A. Marsters, Hartmut Koeppen, Avi Ashkenazi, (unknown)	167
8	CHARACTERIZATION AND HUMANIZATION OF A MONOCLONAL ANTIBODY THAT NEUTRALIZES HUMAN LEUKOCYTE INTERFERON: A CANDIDATE THERAPEUTIC FOR IDDM AND SLE 2001 ·Cytokine ·Anan Chuntharapai, (unknown), Xiaojian Huang, Verna C. Gibbs, (unknown), Leonard G. Presta, Timothy A. Stewart	28
9	Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5 breakdown → 2000 ·Immunity ·Frank Kischkel, David A. Lawrence, Anan Chuntharapai, Peter Schow, (unknown), Avi Ashkenazi	816
10	A NEUTRALIZING MONOCLONAL ANTIBODY SPECIFIC FOR THE DIMER INTERFACE REGION OF IL-8 2000 ·Cytokine ·Laura DeForge, Henry B. Lowman, Steven R. Leong, Anan Chuntharapai, (unknown), C A Hébert	1
11	Determination of Residues Involved in Ligand Binding and Signal Transmission in the Human IFN-α Receptor 2 1999 ·The Journal of Immunology ·Anan Chuntharapai, Verna C. Gibbs, (unknown), (unknown), Scot A. Marsters, Avi Ashkenazi, (unknown), (unknown)	24
12	Structure-Function Study of the Extracellular Domain of the Human IFN-α Receptor (hIFNAR1) Using Blocking Monoclonal Antibodies: The Role of Domains 1 and 2 1998 ·The Journal of Immunology ·(unknown), Anan Chuntharapai, (unknown), S Bass, (unknown), Abraham M. de Vos, Verna C. Gibbs, (unknown)	28
13	Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells 1998 ·European Journal of Immunology ·María José Martínez‐Lorenzo, María A. Álava, Susana Gamen, (unknown), Anan Chuntharapai, Andrés Piñeiro, Javier Naval, Alberto Anel	162
14	[2] Generation of monoclonal antibodies to chemokine receptors 1997 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Anan Chuntharapai, (unknown)	7
15	Interleukin-8 (IL-8), Melanoma Growth-stimulatory Activity, and Neutrophil-activating Peptide Selectively Mediate Priming of the Neutrophil NADPH Oxidase through the Type A or Type B IL-8 Receptor 1996 ·Journal of Biological Chemistry ·Simon P. Green, Anan Chuntharapai, John T. Curnutte	50
16	A Negative Regulatory Region in the Intracellular Domain of the Human Interferon-α Receptor 1996 ·Journal of Biological Chemistry ·Verna C. Gibbs, (unknown), Michel Aguet, Anan Chuntharapai	35
17	Interleukin-8 Receptor β 1995 ·Journal of Biological Chemistry ·Adit Ben‐Baruch, Kathleen Bengali, Arya Biragyn, (unknown), Ji-Ming Wang, Jin Seok Kim, Anan Chuntharapai, Dennis F. Michiel, Joost J. Oppenheim, David J. Kelvin	65
18	Neutralizing monoclonal antibodies to human IL-8 receptor A map to the NH2-terminal region of the receptor. 1994 ·The Journal of Immunology ·Anan Chuntharapai, (unknown), John P. Burnier, William I. Wood, Christopher Hebert, (unknown)	38
19	Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. 1994 ·The Journal of Immunology ·Anan Chuntharapai, (unknown), C A Hébert, (unknown)	187
20	Blocking Monoclonal Antibodies to αVβ3 Integrin: A Unique Epitope of αVβ3 Integrin Is Present on Human Osteoclasts 1993 ·Experimental Cell Research ·Anan Chuntharapai, Sarah Bodary, Michael A. Horton, (unknown)	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact